Targeted Peptides – Help for Lyme

New Drug for Lyme disease: Awaiting preliminary FDA approval.

“To our knowledge, this is the first novel drug candidate that has been proposed for study in the treatment of chronic Lyme Disease post-infection in quite some time.”

"Currently there is no treatment for Lyme Disease once it has develop-ed into its chronic, long-term state, other than antibiotics regimens which, while managing the disease for some of those infected, leaves untouched some of the symptoms for a significant portion of those suffering from this debilitating condition."

Read more about it:

Viral Genetics Submits Pre-IND Document for Lyme Disease Drug Candidate to FDA – MarketWatch.

Tick art by Mackenzie Damon (@2012)


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s